SCHEMBL3344520

SCHEMBL3344520

O=[N+]([O-])c1cnc(N2CCOCC2)c(-n2ccnn2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2C9 P11712 3/20 0.47
HPGD P15428 1/20 0.47
EGLN2 Q96KS0 2/20 0.46
EGLN1 Q9GZT9 2/20 0.46
EGLN3 Q9H6Z9 2/20 0.46
MAPK1 P28482 3/20 0.44
HTT P42858 2/20 0.44
HIF1AN Q9NWT6 1/20 0.43
POLB P06746 3/20 0.42
MAPT P10636 5/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2C19 P33261 1/20 0.39
LMNA P02545 2/20 0.39
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
SLC6A9 P48067 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14910028 0.84 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2C9HPGDMAPK1
SCHEMBL14910449 0.82 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP2C9HPGDMAPK1
SCHEMBL3344799 0.79 EGLN2 (0.47) EGLN2EGLN1EGLN3HTTHIF1AN
SCHEMBL4675601 0.76 ALDH1A1 (0.74) ALDH1A1CYP1A2CYP2C9HPGDMAPK1
SCHEMBL3544112 0.75 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9HPGDMAPK1
SCHEMBL3363772 0.75 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9HPGDMAPK1
SCHEMBL2145143 0.75 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9HPGDMAPK1
SCHEMBL10076383 0.75 NOTUM (0.44) ALDH1A1CYP1A2CYP2C9MAPK1HTT
SCHEMBL14909313 0.75 NOTUM (0.37) ALDH1A1CYP1A2EGLN2MAPK1HTT
SCHEMBL23580543 0.72 ALDH1A1 (0.40) ALDH1A1EGLN2MAPK1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 EP disclosed
CN-102958918-B Novel tobacco amide derivatives or its salt FUJIFILM CORP. (JP) 2015-12-09 CN disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed
CN-102958918-A Novel nicotinamide derivatives or salts thereof FUJIFILM CORP 2013-03-06 CN disclosed
WO-2012002577-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF 富士フイルム株式会社 (JP) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK ALDH1A1 1638/4885CYP1A2 4413/4885CYP2C9 4459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.